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ABSTRACT
Objective To study the association of cardiac 
rehabilitation and physical activity with temporal changes 
in health- related quality of life (HRQoL) following acute 
myocardial infarction (AMI).
Methods Evaluation of the Methods and Management 
of Acute Coronary Events-3 is a nationwide longitudinal 
prospective cohort study of 4570 patients admitted 
with an AMI between 1 November 2011 and 17 
September 2013. HRQoL was estimated using EuroQol 
5- Dimension-3 Level Questionnaire at hospitalisation, 30 
days, and 6 and 12 months following hospital discharge. 
The association of cardiac rehabilitation and self- 
reported physical activity on temporal changes in HRQoL 
was quantiied using inverse probability of treatment 
weighting propensity score and multilevel regression 
analyses.
Results Cardiac rehabilitation attendees had higher 
HRQoL scores than non- attendees at 30 days (mean 
EuroQol 5- Visual Analogue Scale (EQ- VAS) scores: 71.0 
(SD 16.8) vs 68.6 (SD 19.8)), 6 months (76.0 (SD 16.4) 
vs 70.2 (SD 19.0)) and 12 months (76.9 (SD 16.8) vs 
70.4 (SD 20.4)). Attendees who were physically active 
≥150 min/week had higher HRQoL scores compared 
with those who only attended cardiac rehabilitation at 
30 days (mean EQ- VAS scores: 79.3 (SD 14.6) vs 70.2 
(SD 17.0)), 6 months (82.2 (SD 13.9) vs 74.9 (SD 16.7)) 
and 12 months (84.1 (SD 12.1) vs 75.6 (SD 17.0)). 
Cardiac rehabilitation and self- reported physical activity 
of ≥150 min/week were each positively associated with 
temporal improvements in HRQoL (coeficient: 2.12 
(95% CI 0.68 to 3.55) and 4.75 (95% CI 3.16 to 6.34), 
respectively).
Conclusions Cardiac rehabilitation was independently 
associated with temporal improvements in HRQoL 
at up to 12 months following hospitalisation, with 
such changes further improved in patients who were 
physically active.
INTRODUCTION
Health- related quality of life (HRQoL) is an 
important outcome measure following acute 
myocardial infarction (AMI).1 Healthcare profes-
sionals have historically focused on objective 
measures of poor health, such as mortality and life 
expectancy, but often patients consider improve-
ments to HRQoL equally important to length of 
life.2 The benefits of exercise post- AMI on mortality 
have been demonstrated since the early 1950s, yet 
only recently has its potential to enhance HRQoL 
been recognised in this group.3 4
While cardiac rehabilitation has been associated 
with better HRQoL in patients following AMI,3 
the majority of studies are limited by small sample 
sizes, cross- sectional designs, have limited general-
isability or have not studied repeated (longitudinal) 
measures of HRQoL in populations.57 Moreover, 
the literature suggests that cardiac rehabilitation 
is an underused intervention with referral rates 
reported at around 50% and uptake frequently 
lower than this.8 9
The Evaluation of the Methods and Manage-
ment of Acute Coronary Events (EMMACE)-3 is 
a national longitudinal prospective cohort study 
that collected data pertaining to the referral and 
uptake of cardiac rehabilitation in the National 
Health Service (NHS) of England. Among other 
patient- level items, it collected HRQoL scores, 
self- reported physical activity status, comorbidi-
ties, treatments and clinical outcomes for patients 
who were admitted to 48 hospitals between 1 
November 2011 and 17 September 2013 with an 
acute coronary syndrome.10 This study aimed to 
investigate the association of cardiac rehabilita-
tion and temporal changes in HRQoL estimated 
at multiple time points and to explore the impact 
of self- reported physical activity status on HRQoL 
trajectories.
METHODS
Setting and design
The study was based on data from 4570 patients 
who participated in EMMACE-3, a national longi-
tudinal cohort study.10 Eligible patients included all 
adults aged 18 years and over hospitalised with AMI 
(ST- elevation myocardial infarction (STEMI) or 
non- ST- elevation myocardial infarction (NSTEMI)) 
who were admitted to 48 NHS hospitals in England 
between 1 November 2011 and 17 September 
2013. Records for consenting patients were linked 
to the UK Myocardial Ischaemia National Audit 
Project (MINAP) to obtain data about their medical 
history, comorbidities, cardiac biomarkers, type 
of AMI (STEMI or NSTEMI), hospital treatments 
and discharge medications.11 The EMMACE-3 
study protocol, of which this research is a subset, 
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is available online (https:// bmjopen. bmj. com/ content/ 5/ 6/ 
e006256).10
Assessment of HRQoL
The primary outcome, self- reported HRQoL, was quantified 
using EuroQol 5- Dimension-3 Level Questionnaire (EQ- 5D- 3L), 
which has been validated in patients with AMI12 and consists 
of two component parts, a descriptive classification (EuroQol 
5- Dimension (EQ- 5D)) and a visual analogue scale (EuroQol 
5- Visual Analogue Scale (EQ- VAS)). EQ- 5D comprises five 
dimensions: mobility, self- care, usual activities, pain/discom-
fort and anxiety/depression, with each dimension subdivided 
into three levels: no problems, some problems, extreme prob-
lems, indicating a patients perceived level of function. Each 
level carries a weighted score which is combined across the five 
dimensions to total a single index score, which is then stan-
dardised to the UK population.13 For the purposes of this study, 
we combined the levels some problems and extreme problems 
VRWKDWUHVSRQVHVZHUHELQDU\(4'VFRUHVUDQJHGIURPï
to 1.0, with negative scores indicating states worse than death, 
0 indicating no quality of life or death, and 1 indicating full 
health.14 EQ- VAS is an analogue scale of 0100 in which partic-
ipants are required to indicate their own perceived health, with 
0 indicating worst imaginable health state and 100 indicating 
best imaginable health state.15 A difference in a score of 0.05 
for EQ- 5D and 7 for VAS is regarded as clinically important.16 
For EMMACE-3, EQ- 5D- 3L data were collected at hospitalisa-
tion and at 30 days, and 6 and 12 months following discharge 
from the hospital.
Statistical analyses
Baseline characteristics for categorical data were described using 
frequencies and proportions. Normally distributed continuous 
data were described using means and SD, and non- normally 
distributed data were described using medians and IQRs. The 
differences in baseline characteristics between STEMI and 
NSTEMI were summarised using t- tests, χ2 tests, and Wilcoxon 
rank- sum tests appropriate to the data type and distribution.
Propensity score- based weighting coupled with a multilevel 
linear regression model (repeated measurements nested within 
patients and patients nested within hospitals) was applied to 
assess the relationship of attending cardiac rehabilitation on 
HRQoL.17 Briefly, the modelling involved a two- step approach: 
(1) a treatment assignment model estimating the propensity of 
attending cardiac rehabilitation at 30 days following discharge 
from the hospital was used to derive inverse- probability weights 
in order to balance any systematic differences in baseline char-
acteristics between cardiac rehabilitation attendees and non- 
attendees (see online supplementary section 1 and 2) and (2) an 
outcome model assessing the impact of cardiac rehabilitation on 
HRQoL following AMI using a multilevel linear regression fitted 
to the weighted data at 30 days and 6 and 12 months.
Since the weighting was conducted using covariates observed 
at baseline, longitudinal multilevel regression models were 
additionally adjusted for the following patient- level factors in 
order to minimise potential residual confounding: baseline 
EQ- VAS, AMI phenotype (STEMI vs NSTEMI), sex, age, Body 
Mass Index (BMI), Index of Multiple Deprivation (IMD) score, 
smoking status (never vs current or ex- smoker), family history 
of coronary heart disease (CHD), previous angina, history 
of diabetes mellitus, hypertension, heart failure, peripheral 
vascular disease, cerebrovascular disease, chronic renal failure, 
chronic obstructive pulmonary disease (COPD) or asthma, 
hypercholesterolaemia, previous percutaneous coronary inter-
vention (PCI), previous coronary artery bypass graft (CABG) 
surgery, previous AMI, PCI during AMI hospitalisation, CABG 
surgery during AMI hospitalisation, reinfarction during index 
AMI hospitalisation, medications prescribed at discharge from 
the hospital (including aspirin, beta- blockers, statins and ACE 
inhibitors) and self- reported physical activity status. Missing 
data were imputed using multiple imputation by chained equa-
tions (10 datasets from 20 iterations), and a default imputation 
strategy based on clinical expert opinion was implemented for 
selected treatment variables (online supplementary section 2). 
Pooled estimates and accompanying 95% CIs for each model 
were generated according to Rubins rules.18 Analysis were 
performed using STATA MP64 V.14 ( StataCorp, www. stata. com), 
and p values of <0.05 were considered statistically significant.
Patient involvement
While no patients were involved in setting the research ques-
tion or the study design, the work is coauthored by a patient 
representative (GO) who helped with the interpretation of the 
findings and provided a critical review of the manuscript text.
RESULTS
Study sample
From 5557 hospitalisations of consented patients across 48 hospi-
tals, 181 (3.3%) patients withdrew from the study; we excluded 
510 (9.2%) due to failed data linkage to MINAP and 296 
(5.3%) who did not have a discharge diagnosis of AMI, leaving 
an analytical cohort of 4570 (online supplementary eFigure 1). 
For the weighted multilevel linear regression model, we anal-
ysed an effective sample size of 3438 because a further 1132 
patients were excluded due to missing exposure/outcome data. 
Questionnaire response rates were 96.4% (4403/4570), 74.3% 
(3395/4570), 65.1% (2973/4570) and 61.9% (2828/4570) at 
hospitalisation, 30 days, and 6 and 12 months, respectively. 
Sixteen patients (0.3%) died in the hospital. Missing data levels 
were <7% for baseline patient demographic characteristics, 
except for IMD (5.8%), BMI (39.3%), family history of CHD 
(13.1%) and ethnicity (22.0%) (table 1). The mean age for the 
analytical cohort was 63.6 (SD 11.9) years; 25.2% were women; 
76.3% were Caucasian; the median BMI was 27.8 (25.131.3) 
kg/m2; the median IMD score was 18.5 (IQR 11.031.8); and 
65.9% were current or ex- smokers. Comorbidity was common, 
including hypertension (42.7%), angina (19.6%), diabetes 
mellitus (15.9%) and COPD or asthma (12.1%) (table 1).
HRQoL trajectories
For EQ- 5D dimensions, 66.6% (2893/4344) of participants 
UHSRUWHG  SUREOHP DW KRVSLWDOLVDWLRQ ZKLFK LQFUHDVHG WR
70.8% (2356/3326) at 30 days, then decreased to 58.4% 
(1712/2930) at 6 months, and 56.9% (1584/2783) at 12 months. 
Participants reported having the greatest burden of problems (of 
any level) at hospitalisation in usual activities (45.8%), followed 
by mobility (35.5%), pain (32.9%), anxiety (30.2%) and self- 
care (13.8%) (figure 1 and online supplementary eTable 4). 
Each domain improved at each time point over the 12- month 
period except for self- care, which showed a modest increase 
from 7.7% to 8.2% at 6 and 12 months, respectively. Compared 
with the UK averages, participants reported a greater propor-
tion of problems in usual activities, self- care and mobility at 
all time points. Anxiety was reported at a greater proportion 
at hospitalisation and 30 days; however, this then improved to 
below the UK average at 6 and 12 months. At hospitalisation, 
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pain was reported at a similar proportion to the UK average 
but improved at each subsequent follow- up point. Patients with 
167(0, UHSRUWHG DQ LQFUHDVHG IUHTXHQF\ RI  SUREOHP DW
all time points, at hospitalisation (65.5% vs 60.1%), 30 days 
(53.4% vs 48.9%), 6 months (39.9% vs 33.9) and 12 months 
(37.7% vs 30.2%). This pattern of improvement from hospi-
talisation to 12 months was also reflected in the index scores 
of all patients with AMI (EQ- 5D- 3L: 0.74 (SD 0.28) vs 0.79 
(SD 0.26); EQ- VAS: 64.3 (SD 19.9) vs 74.4 (SD 18.5)) (table 2). 
Patients with NSTEMI reported worse HRQoL than those with 
STEMI at each time point except at baseline, such that the mean 
EQ- 5D- 3L scores and EQ- VAS scores were 0.74 vs 0.78 and 69.6 
vs 71.2 at 30 days, 0.78 vs 0.81 and 72.9 vs 75.3 at 6 months, 
and 0.78 vs 0.82 and 73.1 vs 76.5 at 12 months, respectively, for 
NSTEMI compared with STEMI (online supplementary eTable 
5). Furthermore, those who attended cardiac rehabilitation 
DQG UHSRUWHG SK\VLFDO DFWLYLW\ RI  PLQZHHN KDG JUHDWHU
temporal improvements in HRQoL scores compared with those 
ZKRDWWHQGHGDQGUHSRUWHGSK\VLFDODFWLYLW\RIPLQZHHN
30 days (mean EQ- VAS: 79.3 (SD 14.6) vs 70.2 (SD 17.0)), 6 
months (EQ- VAS: 82.2 (SD 13.9) vs 74.9 (SD 16.7)) and 12 
months (EQ- VAS: 84.1 (SD 12.1) vs 75.6 (SD 17.0)) (figure 2 
and online supplementary eTable 6).
Association of cardiac rehabilitation with HRQoL trajectories
Participants who attended cardiac rehabilitation had higher 
HRQoL scores compared with those who did not attend. More-
over, attendees showed a greater temporal improvement at each 
follow- up point: 30 days (mean EQ- VAS: 71.0 (SD 16.8) vs 
68.6 (SD 19.8)), 6 months (EQ- VAS: 76.0 (SD 16.4) vs 70.2 
(SD 19.0)) and 12 months (EQ- VAS: 76.9 (SD 16.8) vs 70.4 
(SD 20.4)). The propensity weighted multilevel model demon-
strated temporal improvements in HRQoL following AMI over 
the 12- month follow- up period (EQ- VAS score coefficient at 6 
months: 3.18 (95% CI 2.22 to 4.14) and at 12 months: 3.81 
Table 1 Patient baseline characteristics stratiied by type of acute myocardial infarction (STEMI vs NSTEMI)
STEMI, n=1856 NSTEMI, n=2714 P value All AMI, n=4570 Missing, n (%)
Variables
  Age (years), mean (SD) 60.9 (11.5) 65.5 (11.9) <0.001 63.6 (11.9) 17 (0.4)
  Women, n (%) 432 (23.3) 720 (26.6) 0.012 1152 (25.2) 15 (0.3)
  IMD score, median (IQR) 19.1 (11.0–34.2) 18.1 (11.0–30.4) 0.010 18.5 (11.0–31.8) 264 (5.8)
  BMI, median (IQR), kg/ m2 27.3 (24.8–30.9) 28.2 (25.3–31.7) <0.001 27.8 (25.1–31.3) 1794 (39.3)
  Ex/current smoking status, n (%) 1251 (67.4) 1761 (64.9) <0.001 3012 (65.9) 143 (3.1)
  Caucasian, n (%) 1415 (76.2) 2071 (76.3) 0.218 3486 (76.3) 1004 (22.0)
  Family history of CHD, n (%) 696 (37.5) 998 (36.8) 0.295 1694 (37.1) 599 (13.1)
Comorbidities
  Previous PCI, n (%) 68 (3.7) 245 (9.0) <0.001 313 (6.9) 170 (3.7)
  Previous CABG surgery, n (%) 39 (2.1) 251 (9.3) <0.001 290 (6.4) 168 (3.7)
  Previous AMI, n (%) 127 (6.8) 506 (18.6) <0.001 633 (13.9) 169 (3.7)
  Previous angina, n (%) 162 (8.7) 734 (27.0) <0.001 896 (19.6) 169 (3.7)
  Chronic renal failure, n (%) 17 (0.9) 106 (3.9) <0.001 123 (2.69%) 180 (3.9)
  Hypertension, n (%) 644 (34.7) 1306 (48.1) <0.001 1950 (42.7) 178 (3.9)
  Chronic heart failure, n (%) 6 (0.3) 72 (2.7) <0.001 78 (1.71) 177 (3.9)
  Hypercholesterolaemia, n (%) 469 (25.3) 927 (34.2) <0.001 1396 (30.6) 216 (4.7)
  Peripheral vascular disease, n (%) 43 (2.3) 109 (4.0) 0.002 152 (3.3) 302 (6.6)
  Asthma/COPD, n (%) 184 (9.9) 370 (13.6) 0.001 554 (12.1) 188 (4.1)
  Cerebrovascular disease, n (%) 52 (2.8) 134 (4.9) 0.001 186 (4.1) 180 (3.9)
  Diabetes mellitus, n (%) 202 (10.9) 524 (19.3) <0.001 726 (15.9) 93 (2.0)
Treatments during hospitalisation
  PCI, n (%) 654 (35.2) 1169 (43.1) <0.001 1823 (39.9) 735 (16.1)
  CABG surgery, n (%) 36 (1.9) 296 (10.9) <0.001 332 (7.3) 735 (16.1)
Discharge medications
  Aspirin, n (%) 1720 (92.7) 2228 (82.1) <0.001 3948 (86.4) 142 (3.1)
  Beta blocker, n (%) 1650 (88.9) 2031 (74.8) <0.001 3681 (80.6) 144 (3.2)
  Statins, n (%) 1714 (92.4) 2245 (82.7) <0.001 3959 (86.6) 141 (3.1)
  ACEi, n (%) 1658 (89.3) 2061 (75.9) <0.001 3719 (81.4) 161 (3.5)
Cardiac rehabilitation
  Cardiac rehabilitation offered at 
baseline, n (%)
1734 (93.4) 2467 (90.9) <0.001 4201 (91.9) 264 (5.8)
Adverse cardiac events
  Deaths in hospital n (%) 2 (0.1) 14 (0.5) 0.022 16 (0.3) 61 (1.3)
  Reinfarction in hospital n (%) 16 (0.9) 14 (0.5) 0.153 30 (0.7) 151 (3.3)
HRQoL
  Baseline EQ- VAS, mean (SD) 65.0 (19.8) 63.8 (20.0) 0.051 64.3 (19.9) 193 (4.2)
ACEi, ACE inhibitor; AMI, acute myocardial infarction; BMI, Body Mass Index; CABG, coronary artery bypass graft; CHD, coronary heart disease; COPD, chronic obstructive 
pulmonary disease; HRQoL, health- related quality of life; IMD, Index of Multiple Deprivation; NSTEMI, non- ST- elevation myocardial infarction; PCI, percutaneous coronary 
intervention; STEMI, ST- elevation myocardial infarction.
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(95% CI 2.72 to 4.90) compared with 30 days). Cardiac reha-
ELOLWDWLRQDQGVHOIUHSRUWHGSK\VLFDODFWLYLW\RIPLQZHHN
were also positively associated with HRQoL (2.12 (95% CI 0.68 
to 3.55) and 4.75 (95% CI 3.16 to 6.34), respectively) (figure 3). 
After standardisation for case mix, there was minimal variance 
between hospitals. However, there was wide variation between 
patients (48.7%) and within patients over time (51.3%) (online 
supplementary eTable 7).
DISCUSSION
In this national longitudinal study of 4570 patients hospitalised 
with AMI, we found that attendance at cardiac rehabilitation 
was associated with a temporal improvement in HRQoL at up to 
12 months following hospital discharge. Moreover, for patients 
ZKRDOVRSDUWLFLSDWHGLQDFWLYLWLHVRIPLQZHHNWKHPDJQL-
tude of the positive association between cardiac rehabilitation 
and improvements in HRQoL was larger.
It has previously been suggested that the minimal clinically 
important difference for HRQoL as measured by EQ- VAS is 7 
points.16 We found that at 12 months, the absolute difference 
in EQ- VAS was 14.9 points when comparing patients who both 
attended cardiac rehabilitation and undertook additional phys-
ical activity with those who did neither (84.1 vs 69.2). More-
over, the absolute difference in EQ- VAS was 6.5 when comparing 
attendees to non- attendees of cardiac rehabilitation alone (76.9 
vs 70.4). The propensity score wei
ghted modelling, on the other hand, found that attending 
FDUGLDFUHKDELOLWDWLRQDQGSK\VLFDODFWLYLW\RIPLQZHHNDW
30 days had a positive impact on changes in HRQoL (EQ- VAS 
score coefficient of 2.12 (95% CI 0.68 to 3.55) and 4.75 (95% 
CI 3.16 to 6.34)). This relates to the average relative increase 
over the follow- up period. Although the coefficients are not 
equal or greater than 7, we considered the positive impact clin-
ically relevant.
Our results build on the existing literature. A systematic 
review of randomised controlled trials reported improve-
ments in HRQoL measures in 14/20 studies for patients with 
AMI, previous coronary revascularisation or established CHD 
who participated in an exercise- based cardiac rehabilitation 
programme compared with those who received standard care.4 
However, they were unable to undertake a meta- analysis due 
to heterogeneity in outcome measures and reporting methods. 
Many previous studies have also been limited by small sample 
sizes and non- randomisation of treatment arms or have been 
predominantly not of UK/European cohorts.1922
Notably, the rehabilitation after myocardial infarction 
(randomised controlled) trial (RAMIT) found no significant 
effect of cardiac rehabilitation on mortality or HRQoL.23 Much 
has been debated regarding these findings particularly as the 
Figure 1 Proportion of patients with acute myocardial infarction who 
reported ≥1 problem across all of the EuroQol 5- Dimension domains 
at baseline, 30 days, and 6 and 12 months of follow- up. UK national 
average included.
Table 2 Mean EQ- 5D- 3L and EQ- VAS scores at baseline, 30 days, and 6 and 12 months of patients attending cardiac rehabilitation versus those 
who did not attend
Variable Attended cardiac rehabilitation Did not attend cardiac rehabilitation P value All AMI, n=4570 Missing, n (%)
EQ- 5D Index score, mean (SD)     
  Hospitalisation (SD) 0.766 (0.264), n=1681 0.754 (0.277), n=874 0.302 0.744 (0.280) 226 (5.0)
  30 days, mean (SD) 0.773 (0.232), n=2259 0.728 (0.278), n=874 <0.001 0.757 (0.250) 1244 (27.2)
  6 months, mean (SD) 0.821 (0.236), n=1862 0.737 (0.290), n=885 <0.001 0.790 (0.261) 1640 (35.9)
  12 months, mean (SD) 0.832 (0.225), n=1725 0.739 (0.294), n=887 <0.001 0.794 (0.260) 1787 (39.1)
EQ- 5D VAS score, mean (SD)     
  Hospitalisation (SD) 65.4 (19.6) n=1,694 64.5 (20.0), n=880 0.312 64.3 (19.9) 193 (4.2)
  30 days, mean (SD) 71.0 (16.8), n=2251 68.6 (19.7), n=865 <0.001 70.2 (17.8) 1269 (27.8)
  6 months, mean (SD) 76.0 (16.4), n=1841 70.2 (19.0), n=867 <0.001 73.9 (17.7) 1691 (37.0)
  12 months, mean (SD) 76.9 (16.8), n=1691 70.4 (20.3), n=884 <0.001 74.4 (18.5) 1840 (40.3)
EQ- 5D- 3L, EuroQol 5- Dimension-3 Level Questionnaire; EQ- VAS, EuroQol Visual Analogue Scale.
Figure 2 Health- related quality of life trajectories of patients with 
acute myocardial infarction according to their attendance at cardiac 
rehabilitation and/or self- reported physical activity of ≥150 min/week.
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majority of the evidence for cardiac rehabilitation is from studies 
conducted prior to modern advancements in pharmacothera-
peutic and invasive coronary strategies; it has been suggested that 
cardiac rehabilitation may no longer possess significant benefits 
for patients.24 However, there were a number of issues which 
may have contributed to the results of RAMIT, including lack of 
sufficient study power and a potential loss of clinical equipoise. 
The UK National Audit of Cardiac Rehabilitation reports that 
only <30% of patients offered cardiac rehabilitation declined 
attending, whereas in RAMIT, there was a 50% risk that partic-
ipants would miss out on cardiac rehabilitation and therefore 
may not have participated.25 26
Observational longitudinal population- based studies such as 
ours negate some of the above issues by allowing the nesting 
of time periods, which enables investigation of trajectories of 
HRQoL and potentially within a much larger cohort of patients 
over time. Our data suggest that cardiac rehabilitation has an 
important role to play in HRQoL recovery after AMI, and 
encouragement of sustained physical activity beyond the initial 
period of cardiac rehabilitation may lead to even greater benefits 
in HRQoL over time.
While there are many strengths to this work, including its 
nationwide and longitudinal design and the efficiency of data 
enhancement through linkage to national clinical registries, we 
acknowledge the inherent weakness in the observational design. 
Foremost is that we do not propose a causal relationship, which 
can only be tested in randomised studies. Nevertheless, we 
undertook a weighted propensity score analysis which will, in 
part, have mitigated some of the confounding by indication. This 
analysis supports the relationship between cardiac rehabilitation 
and temporal improvements in HRQoL. Although we used a 
generic HRQoL indicator, this has previously been validated in 
patients post- AMI, and the domains are typically expected to 
be affected by AMI.12 There was a loss to follow- up of nearly 
40% by 12 months, which is not unexpected when conducting 
cohort studies. This may, however, have resulted in a selection 
bias should those lost had worse HRQoL. Notwithstanding this, 
the multilevel model technique enabled inclusion of all patients 
in the analysis, even if they were not assessed at all follow- up 
points. There is also potential for recall bias or misclassification 
in respect to self- reported physical activity, given that patients 
had to report how often they were physically active for more 
than 15 min in a week and whether this was of light, moderate 
or strenuous in intensity. As with all observational studies, there 
is a possibility that HRQoL after AMI is affected by unmeasured 
confounders, which has not been accounted for in the analysis, 
including coronary anatomy, other comorbidities, variation 
between cardiac rehabilitation programmes, acuity of presenta-
tion and also acuity of intervention.
CONCLUSIONS
This national cohort study of 4570 patients demonstrated that 
cardiac rehabilitation was associated with improved HRQoL. 
Furthermore, it suggests that these benefits were even greater 
IRUWKRVHZKRSDUWLFLSDWHGLQPLQRISK\VLFDODFWLYLW\SHU
week. Therefore, encouraging patients to participate in cardiac 
rehabilitation and to pursue sustained physical activity may be 
important for recovery post- AMI. Further studies are required 
Key messages
What is already known on this subject?
 Ź Cardiac rehabilitation is associated with better health- related 
quality of life (HRQoL) following acute myocardial infarction 
(AMI).
 Ź However, there is a paucity of information about the impact 
of cardiac rehabilitation on temporal changes in HRQoL in the 
modern pharmacotherapeutic and invasive coronary era.
 Ź To date, there are no published nationwide longitudinal 
studies of repeated measures of perceived HRQoL following 
AMI.
What might this study add?
 Ź This national longitudinal cohort study across 48 hospitals of 
4570 patients with AMI found that attendance at a cardiac 
rehabilitation programme was independently associated 
with temporal improvements in HRQoL at up to 12 months 
following hospitalisation, with such changes further improved 
in patients who were physically active.
How might this impact on clinical practice?
 Ź Ensuring the provision of cardiac rehabilitation services that 
enable all patients with AMI to attend may be an important 
determinant of the recovery of HRQoL.
Figure 3 Results of the imputed propensity score weighted multi- level modelling of the association of cardiac rehabilitation and change in EQ- VAS 
following AMI (regression coeficients, 95% conidence intervals). ACEi, ACE inhibitor; AMI, acute myocardial infarction; BMI, Body Mass Index; CABG, 
coronary artery bypass graft; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; EQ- 5D VAS, EuroQol 5- dimension Visual 
Analogue Scale; IMD, Index of Multiple Deprivation; PCI, percutaneous coronary intervention; NSTEMI, non- ST- elevation myocardial infarction.
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to determine if the dose of exercise training and or heightened 
levels of physical activity status alongside cardiac rehabilitation 
may result in even greater benefits for patients.
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